AI News NQ Analysis

[VISCO] March 2026 Revenue NT$348M (YoY +18.2%)

NQ Score 6/100
N1 Content Completeness 5

AI Summary (NQ-processed)

VISCO, a biotechnology and medical care company, announced that its monthly revenue for March 2026 reached NT$348 million, an 18.2% increase compared to the same month last year, indicating steady growth.

AI Analysis